Healthy Clinical Trial
Official title:
The Effect of Hemodialysis Patients' Attitudes Towards Diet Therapy on Dialysis Symptoms: A Randomized Controlled Clinical Study
NCT number | NCT06215339 |
Other study ID # | Hm20231001 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 1, 2023 |
Est. completion date | July 1, 2023 |
Verified date | January 2024 |
Source | Gümüshane University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study determined the effect of dietary education given to hemodialysis patients on dietary treatment and symptoms.
Status | Completed |
Enrollment | 60 |
Est. completion date | July 1, 2023 |
Est. primary completion date | June 1, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: Being =18 years old, - Agreeing to participate in the research, - Being literate, - Being able to communicate verbally, - Receiving outpatient HD treatment three sessions a week at the same institution, - No impairment in mental and cognitive functions, - Has been receiving HD treatment for at least three months (to be defined as a chronic HD program) Exclusion Criteria: - Refusal to participate in the research, - Being on peritoneal dialysis, - Being diagnosed with a psychiatric disorder diagnosed by a psychiatrist, - The general condition (hemodynamically) is unstable (heart rate < 100 mm/Hg or diastolic BP< 60 mm/Hg), |
Country | Name | City | State |
---|---|---|---|
Turkey | Gümüshane Üniversitesi | Gümüshane | Kelkit |
Lead Sponsor | Collaborator |
---|---|
Dilan aktepe cosar |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Hemodialysis Patients' Attitude Scale Towards Diet Therapy (HDTO)" | "HDTÖ" (HD Dietary Attitude Scale):
Each item is scored as 1-Strongly Agree, 2-Agree, 3-Disagree, 4-Strongly Disagree. The scale comprises three sub-dimensions: |
4 week | |
Secondary | "Dialysis Symptom Index (DSI)" | this scale assesses the emotional and physical symptoms of dialysis patients and the severity of these symptoms, consisting of a total of 30 items | 4 week |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |